Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Curr Protoc Microbiol ; Chapter 14: Unit 14A.2, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21538302

RESUMO

Invitrogen's Gateway technology is a recombination-based cloning method that allows for rapid transfer of numerous open reading frames (ORFs) into multiple plasmid vectors, making it useful for diverse high-throughput applications. Gateway technology has been utilized to create an ORF library for Myxoma virus (MYXV), a member of the Poxviridae family of DNA viruses. MYXV is the prototype virus for the genus Leporipoxvirus, and is pathogenic only in European rabbits. MYXV replicates exclusively in the host cell cytoplasm, and its genome encodes 171 ORFs. A number of these ORFs encode proteins that interfere with or modulate host defense mechanisms, particularly the inflammatory responses. Furthermore, MYXV is able to productively infect a variety of human cancer cell lines and is being developed as an oncolytic virus for treating human cancers. MYXV is therefore an excellent model for studying poxvirus biology, pathogenesis, and host tropism, and a good candidate for ORFeome development.


Assuntos
Expressão Gênica , Myxoma virus/genética , Proteínas Virais/biossíntese , Animais , Clonagem Molecular/métodos , Biblioteca Gênica , Vetores Genéticos , Humanos , Myxoma virus/patogenicidade , Vírus Oncolíticos/genética , Vírus Oncolíticos/patogenicidade , Plasmídeos , Coelhos , Recombinação Genética
2.
Curr Protoc Microbiol ; Chapter 14: Unit 14A.1, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20440681

RESUMO

Myxoma virus (MYXV) is a member of the Poxviridae family and prototype for the genus Leporipoxvirus. It is pathogenic only for European rabbits, in which it causes the lethal disease myxomatosis, and two North American species, in which it causes a less severe disease. MYXV replicates exclusively in the cytoplasm of the host cell. Although not infectious in humans, its genome encodes proteins that can interfere with or modulate host defense mechanisms; it is able to productively infect a number of human cancer cell lines, but not normal human cells, and has also been shown to increase survival time in mouse models of human glioma. These characteristics suggest that MYXV could be a viable therapeutic agent, e.g., in anti-inflammatory or anti-immune therapy, or as an oncolytic agent. MYXV is also an excellent model for poxvirus biology, pathogenesis, and host tropism studies. It is easily propagated in a number of cell lines, including adherent cells and suspension cultures, and minimal purification is required to provide a stock for in vivo and in vitro studies.


Assuntos
Myxoma virus/crescimento & desenvolvimento , Myxoma virus/isolamento & purificação , Virologia/métodos , Animais , Linhagem Celular Tumoral , Humanos , Myxoma virus/patogenicidade , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA